CUFRIO-AM
Terbutaline 1.25mg,Ambroxol Hcl 15mg, Guaiphenesin 50mg & Menthol 1mg Syrup
Product Technical Snapshot
Official pharmaceutical registration and manufacturing parameters
| Brand Name | CUFRIO-AM |
| Active Formulation (Salt) | Terbutaline 1.25mg,Ambroxol Hcl 15mg, Guaiphenesin 50mg & Menthol 1mg Syrup |
| Dosage Form | SYRUPS |
| Packaging Presentation | 100ml |
| Therapeutic Category | SYRUPS |
| Regulatory Classification | Schedule H Prescription Drug |
| Pharmacopoeial Standard | IP / BP / USP Pharmacopoeial Standards |
| Quality Certifications | WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility |
| Marketed & Distributed By | Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana) |
| B2B Franchise Availability | Monopoly PCD Franchise rights available across all Indian districts |
What is CUFRIO-AM?
Therapeutic monograph and clinical profile
CUFRIO-AM (Terbutaline 1.25mg,Ambroxol Hcl 15mg, Guaiphenesin 50mg & Menthol 1mg Syrup) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 100ml, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Productive Cough (Wet Cough) / Bronchitis.
Key Formulation Highlights
Why healthcare professionals recommend CUFRIO-AM
Therapeutic Uses & Clinical Indications
Conditions and clinical disorders managed by this medicine
Recommended Clinical Indications:
Productive Cough (Wet Cough) / Bronchitis
Pharmacological Mechanism of Action
How CUFRIO-AM acts biochemically in the body
Delivers targeted active therapeutic release with rapid absorption and high safety profile.
Dosage & Administration Guidance
Proper usage directions under clinical supervision
As directed by the physician or healthcare professional. Take with water at prescribed intervals.
Precautions, Warnings & Contraindications
Safety guidelines and patient health considerations
Clinical Safety & Medical Advice:
Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.
Possible Side Effects
Tolerability profile and reporting
Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.
Storage & Handling Instructions
Maintaining formulation stability and shelf-life
Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.
Exclusive PCD Pharma Franchise Opportunity for CUFRIO-AM
Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for CUFRIO-AM across India with comprehensive visual aids, prompt dispatch, and high profit margins.
Frequently Asked Questions (FAQs)
Common queries regarding CUFRIO-AM
What is CUFRIO-AM used for?
What is the printed packaging and MRP of CUFRIO-AM?
How can I get monopoly PCD franchise for CUFRIO-AM?
Related Formulations in SYRUPS
Explore complementary WHO-GMP certified healthcare formulations
